IFOM

Silvia Marsoni Lab

Silvia Marsoni

Silvia Marsoni

I have been active in cancer research for more than 30 years, throughout which I have established a record of accomplishments in the field of drug development and clinical trial methodology.

read more

Contact the researcher

Precision Oncology

“And that’s the promise of precision medicine -- delivering the right treatments, at the right time, every time to the right person”. B.Obama, January 30, 2015
Translating preclinical research into clinical benefit for cancer patients is a challenge that can only be accomplished by a multidisciplinary research network.

read more

Laboratory location: Milan, Italy

Last publications

  • Siravegna G, Lazzari L, Crisafulli G, Sartore-Bianchi A, Mussolin B, Cassingena A, Martino C, Lanman RB, Nagy RJ, Fairclough S, Rospo G, Corti G, Bartolini A, Arcella P, Montone M, Lodi F, Lorenzato A, Vanzati A, Valtorta E, Cappello G, Bertotti A, Lonardi S, Zagonel V, Leone F, Russo M, Balsamo A, Truini M, Di Nicolantonio F, Amatu A, Bonazzina E, Ghezzi S, Regge D, Vanzulli A, Trusolino L, Siena S, Marsoni S, Bardelli A.
    Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer.
    Cancer Cell. 2018 Jul 9;34(1):148-162.e7. doi:10.1016/j.ccell.2018.06.004. PubMed PMID:29990497.

  • Siena S, Sartore-Bianchi A, Marsoni S, Hurwitz HI, McCall SJ, Penault-Llorca F, Srock S, Bardelli A, Trusolino L.
    Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.
    Ann Oncol. 2018 May 1;29(5):1108-1119. doi: 10.1093/annonc/mdy100. PubMed PMID: 29659677; PubMed Central PMCID: PMC5961091.

  • Martinelli E, Troiani T, Sforza V, Martini G, Cardone C, Vitiello PP, Ciardiello D, Rachiglio AM, Normanno N, Sartore-Bianchi A, Marsoni S, Bardelli A, Siena S, Ciardiello F.
    Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case.
    ESMO Open. 2018 Jan 10;3(1):e000299. doi:10.1136/esmoopen-2017-000299. eCollection 2018. PubMed PMID: 29387480; PubMed Central PMCID: PMC5786925.

Group members

Clinical Trial Coordinator
Luraghi Paolo
Translational Project Manager
Lazzari Luca
IT Programmer
Soffientini Chiara
Junior Data Manager
Pagano Roberta
JTranslational/Clinical Project Manager
Voli Florida

(update: Mar 2021)

In the press

Ecco come la «biopsia liquida» potrebbe evitare la chemioterapia
2021.03.31

Corrieredellasera.it | Adriana Bazzi

Il Dna tumorale nel sangue per testare il rischio recidiva
2021.03.31

Il Secolo XIX | Federico Mereta

Tumore del colon: la biopsia liquida indirizza il trattamento post chirurgico
2021.03.31

CRONACHEDISCIENZA.IT

Media